Postchemotherapy staging laparotomy in Hodgkin's disease.

Postchemotherapy staging laparotomy in Hodgkin's disease. Br J Cancer (1982) 0.75

Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission. Ann Intern Med (1973) 1.27

Post-treatment laparotomy in the management of Hodgkin's disease. Lancet (1978) 1.23

Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease. Br J Cancer (1979) 1.19

Adriamycin, bleomycin, vinblastine and imidazole carboxamide (ABVD) therapy for advanced Hodgkin's disease resistant to mustine, vinblastine, procarbazine and prednisolone (MVPP). Cancer Chemother Pharmacol (1979) 0.95

Long-term results of the E.O.R.T.C. randomized study of irradiation and vinblastine in clinical stages I and II of Hodgkin's disease. Eur J Cancer (1979) 0.95

Survival of patients with breast cancer attending Bristol Cancer Help Centre. Lancet (1990) 7.04

Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet (1980) 4.21

Bone disease after jejuno-ileal bypass for obesity. Lancet (1978) 3.84

Combined management of malignant teratoma of the testis. Lancet (1979) 3.12

Failure of chemotherapy to prolong survival in a group of patients with metastatic breast cancer. Lancet (1980) 2.82

In vitro and in vivo radiosensitivity of human tumour cells obtained from a pancreatic carcinoma xenograft. Nature (1976) 2.77

Immunotherapy for acute myelogenous leukaemia. Br J Cancer (1973) 2.67

Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys (1979) 2.63

Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol (1982) 2.50

Cyclosporin A for the treatment of graft-versus-host disease in man. Lancet (1979) 2.48

High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. Lancet (1983) 2.33

Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist. Lancet (1987) 2.09

Detection of micrometastases in patients with primary breast cancer. Lancet (1983) 2.07

The place of bone-marrow transplantation in acute myelogenous leukaemia. Lancet (1980) 2.03

Parenteral acyclovir therapy for herpesvirus infections in man. Lancet (1979) 1.99

Assessment of biochemical tests to screen for metastases in patients with breast cancer. Lancet (1980) 1.88

Orchiectomy alone for Stage I testicular non-seminoma. A progress report on the Royal Marsden Hospital study. Br J Urol (1983) 1.87

The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model. Br J Cancer Suppl (1980) 1.85

The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP). Br J Cancer (1983) 1.84

Survey of treatment of primary breast cancer in Great Britain. Br Med J (Clin Res Ed) (1985) 1.80

Effect of age at orchidopexy on risk of testicular cancer. Lancet (1986) 1.80

Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet (1987) 1.79

Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr (1981) 1.79

Variation in response of xenografts of colo-rectal carcinoma to chemotherapy. Br J Cancer (1978) 1.77

Assessment of response of bone metastases to systemic treatment in patients with breast cancer. Cancer (1983) 1.73

Diagnosing breast carcinoma in young women. BMJ (1991) 1.71

Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia. Lancet (1977) 1.69

The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol (1984) 1.68

The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg (1980) 1.63

Effect of antilymphocyte serum on the growth of Hep 2 and HeLa cells in mice. Nature (1968) 1.58

Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours. Lancet (1982) 1.58

Treatment of gross obesity by jejunal bypass. Br Med J (1974) 1.55

The response to chemotherapy of a variety of human tumour xenografts. Br J Cancer (1983) 1.53

Topical calcipotriol treatment in advanced breast cancer. Lancet (1991) 1.53

Estrogen and progesterone receptors in the normal female breast. Cancer Res (1991) 1.50

Effect of high-dose melphalan on marrow and intestinal epithelium in mice pretreated with cyclophosphamide. Br J Cancer (1978) 1.48

Biochemical markers in human breast cancer. Lancet (1977) 1.48

Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates. Lancet (1987) 1.46

Growth of human tumour cell colonies from biopsies using two soft-agar techniques. Br J Cancer (1978) 1.46

Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors. Br J Urol (1981) 1.46

The therapeutic response of bronchial carcinoma xenografts: a direct patient-xenograft comparison. Br J Cancer Suppl (1980) 1.44

Clinical examination, xeromammography, and fine-needle aspiration cytology in diagnosis of breast tumours. Br Med J (1978) 1.44

A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. Br J Cancer (1977) 1.43

Physical test for distant metastases in patients with breast cancer. J R Soc Med (1980) 1.42

Methotrexate-induced malabsorption in children with acute lymphoblastic leukaemia. Br Med J (1977) 1.41

Acceleration of bone-marrow recovery by pre-treatment with cyclophosphamide in patients receiving high-dose melphalan. Lancet (1978) 1.40

A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717. J Clin Oncol (1986) 1.40

Reversal of jejunoileal bypass in patients with morbid obesity. Br J Surg (1994) 1.39

Technique for abdominal radical total gastrectomy. Br J Surg (1989) 1.39

Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up. Eur J Cancer (1991) 1.39

Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br J Cancer (1981) 1.39

High-dose methylprednisolone sodium succinate as a single agent in relapsed childhood acute lymphoblastic leukaemia. Med Pediatr Oncol (1992) 1.39

Explanations for weight loss after ileojejunal bypass in gross obesity. Br Med J (1976) 1.37

High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma. Br J Cancer (1982) 1.37

Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases. Br Med J (Clin Res Ed) (1987) 1.36

Transplantation of primary explants of human tumour to mice treated with antilymphocyte serum. Br J Cancer (1970) 1.36

4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer. Lancet (1984) 1.35

Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial. Br Med J (Clin Res Ed) (1981) 1.33

Combination chemotherapy in advanced and recurrent Hodgkin's disease. Natl Cancer Inst Monogr (1973) 1.33

Human tumour xenografts established and serially transplanted in mice immunologically deprived by thymectomy, cytosine arabinoside and whole-body irradiation. Br J Cancer (1980) 1.31

Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet (1983) 1.31

Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot study. Br J Cancer (1975) 1.31

Tic-related vs. non-tic-related obsessive compulsive disorder. Anxiety (1997) 1.31

In vitro radiation response of cells from four human tumors propagated in immune-suppressed mice. Cancer Res (1978) 1.31

Transplantation of human tumour to immune deprived mice treated with anti-thymocyte serum. Br J Cancer (1973) 1.30

Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice. Br J Cancer (1979) 1.30

A 13-year review of jejunoileal bypass. Br J Surg (1985) 1.29

The role of computed tomography in the management of testicular teratoma. Clin Radiol (1979) 1.28

Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study. Lancet (1999) 1.28

Aminoglutethimide in treatment of metastatic breast carcinoma. Lancet (1978) 1.27

Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma. Br J Cancer (1984) 1.25

Advanced seminoma: treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8). Br J Cancer (1985) 1.24

Growth factor expression in normal, benign, and malignant breast tissue. Br Med J (Clin Res Ed) (1988) 1.24

Influence of tumour size on radiosensitization by misonidazole. Br J Cancer Suppl (1978) 1.24

Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years' follow-up. Eur J Cancer (1991) 1.23

Testicular tumours. Clin Endocrinol Metab (1975) 1.20

The intragastric balloon: a novel idea proved ineffective. Br J Surg (1987) 1.20

Human breast-cancer xenografts in immune-suppressed mice. Br J Cancer (1980) 1.20

Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease. Br J Cancer (1979) 1.19

The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur J Cancer (1997) 1.18

Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy. Br J Cancer (1973) 1.17

Children fathered by men treated for testicular cancer. Lancet (1985) 1.16

Etoposide as a single agent in relapsed advanced lymphomas. A phase II study. Cancer Chemother Pharmacol (1982) 1.15

Chemotherapy of human breast-carcinoma xenografts. Br J Cancer (1980) 1.15

Safe method of collecting leukaemia cells from patients with acute leukaemia for use as immunotherapy. Br Med J (1974) 1.15

Chemotherapy and irradiation in childhood Hodgkin's disease. Arch Dis Child (1984) 1.15

Changing distribution of adenocarcinoma of the stomach. Br J Surg (1987) 1.14

Simple nontoxic treatment of advanced metastatic seminoma with carboplatin. J Clin Oncol (1989) 1.14

Proliferation characteristics of the various classes of cells in Hodgkin's disease. Cancer (1969) 1.14

Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours. Eur J Cancer Clin Oncol (1989) 1.13